• Users Online: 57
  • Print this page
  • Email this page
Year : 2014  |  Volume : 4  |  Issue : 3  |  Page : 137-140

Amantadine-related corneal edema and endothelial cell loss: Four case reports

1 Department of Ophthalmology, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan
2 Department of Ophthalmology, Changhua Christian Hospital, Changhua, Taiwan

Correspondence Address:
Shiuh Liang Hsu
Department of Ophthalmology, Kaohsiung Medical University Chung-Ho Memorial Hospital, Number 100, Tzyou 1st Road, Sanmin District, Kaohsiung City 807
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.1016/j.tjo.2014.04.003

Rights and Permissions

Amantadine is widely used in treating influenza A, hepatitis, Parkinson’s disease, and fatigue in multiple sclerosis. In the past, only a few case reports have demonstrated that amantadine is associated with corneal edema, endothelial dysfunction, and other corneal comorbidity. We herein present four cases with reversible corneal edema and endothelial loss after taking amantadine, including two cases with delayed presentation of corneal edema after use of amantadine for 18 months and 12 months.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded102    
    Comments [Add]    
    Cited by others 5    

Recommend this journal